JP2024535388A5 - - Google Patents
Info
- Publication number
- JP2024535388A5 JP2024535388A5 JP2024518651A JP2024518651A JP2024535388A5 JP 2024535388 A5 JP2024535388 A5 JP 2024535388A5 JP 2024518651 A JP2024518651 A JP 2024518651A JP 2024518651 A JP2024518651 A JP 2024518651A JP 2024535388 A5 JP2024535388 A5 JP 2024535388A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- subject
- conjugate
- compound according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163248520P | 2021-09-26 | 2021-09-26 | |
| US63/248,520 | 2021-09-26 | ||
| PCT/US2021/058495 WO2022099159A1 (en) | 2020-11-08 | 2021-11-08 | Oligonucleotide compositions and methods thereof |
| USPCT/US2021/058495 | 2021-11-08 | ||
| US202263331756P | 2022-04-15 | 2022-04-15 | |
| US63/331,756 | 2022-04-15 | ||
| US202263397320P | 2022-08-11 | 2022-08-11 | |
| US63/397,320 | 2022-08-11 | ||
| PCT/US2022/044765 WO2023049475A1 (en) | 2021-09-26 | 2022-09-26 | Oligonucleotide compositions and methods thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535388A JP2024535388A (ja) | 2024-09-30 |
| JP2024535388A5 true JP2024535388A5 (cg-RX-API-DMAC7.html) | 2025-10-07 |
Family
ID=85721200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518651A Pending JP2024535388A (ja) | 2021-09-26 | 2022-09-26 | オリゴヌクレオチド組成物及びその方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250333740A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4396354A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024535388A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240063964A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022352779A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3232070A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2024000856A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2024005352A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL311625A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024003612A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023049475A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014010250A1 (en) | 2012-07-13 | 2014-01-16 | Chiralgen, Ltd. | Asymmetric auxiliary group |
| EP3094728B1 (en) | 2014-01-16 | 2022-03-09 | Wave Life Sciences Ltd. | Chiral design |
| CN117965536A (zh) | 2015-07-22 | 2024-05-03 | 波涛生命科学有限公司 | 寡核苷酸组合物及其方法 |
| MA46427A (fr) | 2015-10-09 | 2018-08-15 | Wave Life Sciences Ltd | Compositions d'oligonucléotides et procédés associés |
| US11013757B2 (en) | 2016-06-03 | 2021-05-25 | Wave Life Sciences Ltd. | Oligonucleotides, compositions and methods thereof |
| WO2018098264A1 (en) | 2016-11-23 | 2018-05-31 | Wave Life Sciences Ltd. | Compositions and methods for phosphoramidite and oligonucleotide synthesis |
| WO2018237194A1 (en) | 2017-06-21 | 2018-12-27 | Wave Life Sciences Ltd. | Compounds, compositions and methods for synthesis |
| CN111108096A (zh) | 2017-09-18 | 2020-05-05 | 波涛生命科学有限公司 | 寡核苷酸制备技术 |
| JP2021521140A (ja) | 2018-04-12 | 2021-08-26 | ウェイブ ライフ サイエンシズ リミテッドWave Life Sciences Ltd. | オリゴヌクレオチド組成物及びその使用方法 |
| CA3098624A1 (en) | 2018-05-11 | 2019-11-14 | Wave Life Sciences Ltd. | Oligonucleotide compositions and methods of use thereof |
| AU2020241559A1 (en) | 2019-03-20 | 2021-11-11 | Wave Life Sciences Ltd. | Technologies useful for oligonucleotide preparation |
| MX2021012981A (es) | 2019-04-25 | 2022-01-18 | Wave Life Sciences Ltd | Composiciones de oligonucleotido y metodos de uso de las mismas. |
| WO2026077951A1 (en) | 2024-10-07 | 2026-04-16 | Vico Therapeutics B.V. | Improved aon for rna editing |
| WO2026096688A1 (en) * | 2024-10-30 | 2026-05-07 | Wave Life Sciences Ltd. | Oligonucleotide compositions and methods thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008086524A2 (en) * | 2007-01-11 | 2008-07-17 | University Of Florida Research Foundation, Inc. | Alpha-1-antitrypsin variants and uses thereof |
| EP3452596A4 (en) * | 2016-05-04 | 2020-03-18 | Wave Life Sciences Ltd. | OLIGONUCLEOTIDE COMPOSITIONS AND RELATED METHODS |
| WO2020001793A1 (en) * | 2018-06-29 | 2020-01-02 | Eberhard-Karls-Universität Tübingen | Artificial nucleic acids for rna editing |
| WO2020168135A1 (en) * | 2019-02-13 | 2020-08-20 | Beam Therapeutics Inc. | Compositions and methods for treating alpha-1 antitrypsin deficiency |
| CA3154768A1 (en) * | 2019-10-06 | 2021-04-15 | Wave Life Sciences Ltd. | Oligonucleotide compositions and methods of use thereof |
| JP2023548584A (ja) * | 2020-11-08 | 2023-11-17 | ウェイブ ライフ サイエンシズ リミテッド | オリゴヌクレオチド組成物及びその方法 |
-
2022
- 2022-09-26 CA CA3232070A patent/CA3232070A1/en active Pending
- 2022-09-26 WO PCT/US2022/044765 patent/WO2023049475A1/en not_active Ceased
- 2022-09-26 EP EP22873720.1A patent/EP4396354A4/en active Pending
- 2022-09-26 US US18/695,346 patent/US20250333740A1/en active Pending
- 2022-09-26 IL IL311625A patent/IL311625A/en unknown
- 2022-09-26 KR KR1020247012540A patent/KR20240063964A/ko active Pending
- 2022-09-26 AU AU2022352779A patent/AU2022352779A1/en active Pending
- 2022-09-26 JP JP2024518651A patent/JP2024535388A/ja active Pending
- 2022-09-26 MX MX2024003612A patent/MX2024003612A/es unknown
-
2024
- 2024-03-22 CL CL2024000856A patent/CL2024000856A1/es unknown
- 2024-05-07 CO CONC2024/0005352A patent/CO2024005352A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7034133B2 (en) | Oligonucleotide analogues | |
| JP5677716B2 (ja) | オリゴヌクレオチド類似体を含むキット及び方法並びにオリゴヌクレオチド類似体の使用 | |
| US8080644B2 (en) | Oligonucleotide analogues | |
| JP2022551124A5 (cg-RX-API-DMAC7.html) | ||
| JP2023548584A5 (cg-RX-API-DMAC7.html) | ||
| US5399676A (en) | Oligonucleotides with inverted polarity | |
| US5721218A (en) | Oligonucleotides with inverted polarity | |
| JP2004500330A (ja) | グアニジニウム官能化オリゴマーとその製造法 | |
| JP2002527523A (ja) | 機能付与したピリミジン誘導体 | |
| JPH05504553A (ja) | 新規の結合を有するオリゴヌクレオチドアナログ | |
| JPH09511250A (ja) | 核酸治療に有用な修飾オリゴヌクレオチド及び中間体 | |
| AU2022352779A1 (en) | Oligonucleotide compositions and methods thereof | |
| CN1118140A (zh) | 为提高在酸性pH的稳定性而改性的低聚核苷酸 | |
| JPH10509464A (ja) | L−ヌクレオシド二量体組成物およびその治療目的の使用 | |
| JPH09506770A (ja) | c−erbBの発現が関与する疾患を予防及び治療するためのアンチセンス核酸 | |
| WO2019182037A1 (ja) | 毒性が低減されたアンチセンスオリゴヌクレオチド | |
| CN119137272A (zh) | 血管紧张素原调节组合物和其使用方法 | |
| Kiviniemi et al. | Solid-supported 2′-O-glycoconjugation of oligonucleotides by azidation and click reactions | |
| JP3142574B2 (ja) | 2′,5′ホスホロチオエート/ホスホジエステルオリゴアデニレートおよびその抗ウィルス用途 | |
| AU2002325599B2 (en) | Oligonucleotide analogues | |
| Kvasyuk et al. | Nucleotides. Part LVI. Synthesis and biological activity of modified (2′–5′) triadenylates containing 2′‐terminal 2′, 3′‐dideoxy‐3′‐fluoroadenosine derivatives | |
| JP2025526994A5 (cg-RX-API-DMAC7.html) | ||
| Ademola | Synthetic nucleotides and their biological applications | |
| JPWO1996018640A1 (ja) | アンチセンス核酸同族体 |